Yamada, Yosuke http://orcid.org/0000-0001-7952-2706
Belharazem-Vitacolonnna, Djeda
Bohnenberger, Hanibal
Weiß, Christel http://orcid.org/0000-0002-8692-5690
Matsui, Naoko
Kriegsmann, Mark
Kriegsmann, Katharina
Sinn, Peter
Simon-Keller, Katja
Hamilton, Gerhard
Graeter, Thomas
Preissler, Gerhard
Ott, German
Schölch, Sebastian
Nakajima, Naoki
Yoshizawa, Akihiko http://orcid.org/0000-0003-1462-7341
Haga, Hironori http://orcid.org/0000-0003-4322-9561
Date, Hiroshi http://orcid.org/0000-0001-7262-6000
Thomas, Roman K.
Petrini, Iacopo http://orcid.org/0000-0002-7752-6866
Giaccone, Giuseppe http://orcid.org/0000-0002-7392-1965
Ströbel, Philipp
Marx, Alexander http://orcid.org/0000-0001-9722-2483
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (JP21K06902)
Deutsche Forschungsgemeinschaft (413326622)
Article History
Received: 6 May 2022
Revised: 8 November 2022
Accepted: 10 November 2022
First Online: 19 November 2022
Competing interests
: RT reports receiving grants, personal fees, and other support from Roche; personal fees and other support from Johnson and Johnson, AstraZeneca, Merck, Epiphanes Inc., PearlRiver Bio, Bayer, and CDL Therapeutics; other support from Novartis, GlaxoSmithKline; and personal fees from New Oncology AG, Clovis, Daiichi-Sankyo, Boehringer Ingelheim, Merck Sharp & Dohme, Eli Lilly, Sanofi-Aventis, and Puma outside of the submitted work. The remaining authors declare no competing interest.